Lynx Biosciences, Inc.

📍 San Diego, United States🗓 Founded 2015👥 12 employees💰 Last funded Jan 2021
Biotechnology Research🌐 lynx.bio
Website LinkedIn
Lynx Biosciences | Reimagining Translational Research with Patient-Centric Models Lynx Biosciences (LynxBio) is reshaping translational and reverse translational research by combining patient-derived cell models, microphysiological systems (MPS), and integrated multi-omic analyses to generate clinically meaningful insights—earlier and without reliance on animal models. Our platform supports high-content functional profiling of antibody and cell-based therapies in complex ex vivo co-cultures. These models preserve the native biology of the tumor and immune microenvironment, enabling more predictive, human-relevant data from the outset. As the field shifts toward more scalable, patient-centric approaches to drug development, LynxBio offers a solution built to meet this moment. We work across oncology and immunology indications to: • Profile therapeutic activity in ex vivo models • Integrate imaging, cytokine analysis, and transcriptomics from the same culture • Identify predictive biomarkers and stratify responders • Uncover resistance mechanisms and guide target refinement Our approach enables the resolution of responder and non-responder profiles, mechanistic biomarkers, and functional signatures from limited clinical material—accelerating the development of novel biologics and cell-engaging therapies. Whether you are advancing bispecific antibodies, cell engagers, or radiotherapeutics, LynxBio offers a plug-in, human-relevant platform to de-risk development, guide patient selection, and inform smarter, earlier decisions. Unlock deeper insight from fewer cells. Partner with LynxBio.
4
Total investors
0
Early stage
3
Mid stage
1
Late stage
2015
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
4
Investor activity2018–2021 · investors recorded per year
201812020220211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Lynx Biosciences, Inc.?
Lynx Biosciences, Inc. has 4 investors on record on gritt.io, 3 mid-stage and 1 late-stage investors.
When did Lynx Biosciences, Inc. last raise funding?
The most recent investment in Lynx Biosciences, Inc. recorded on gritt.io was in January 2021.
When was Lynx Biosciences, Inc. founded?
Lynx Biosciences, Inc. was founded in 2015.
What industry is Lynx Biosciences, Inc. in?
Lynx Biosciences, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Lynx Biosciences, Inc. based?
Lynx Biosciences, Inc. is headquartered in San Diego, United States.